<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://economictimes.indiatimes.com/markets/stocks/news/unichem-lab-shares-rise-over-7-after-usfda-approval-for-hypertension-drug/articleshow/72218986.cms"/>
    <meta property="og:site_name" content="The Economic Times"/>
    <meta property="article:published_time" content="2019-11-25T06:16:00+00:00"/>
    <meta property="og:title" content="Unichem Lab shares rise over 7% after USFDA approval for hypertension drug"/>
    <meta property="og:description" content="Shares of the drug firm gained 7.04 per cent to trade at Rs 164 on the BSE."/>
  </head>
  <body>
    <article>
      <h1>Unichem Lab shares rise over 7% after USFDA approval for hypertension drug</h1>
      <h2>Shares of the drug firm gained 7.04 per cent to trade at Rs 164 on the BSE.</h2>
      <address><time datetime="2019-11-25T06:16:00+00:00">25 Nov 2019, 06:16</time> by <a rel="author">PTI</a></address>
      <figure>
        <img src="https://img.etimg.com/thumb/msid-72218976,width-640,imgsize-210422,resizemode-3/pharma.jpg"/>
        <figcaption>Unichem Laboratories on Friday said it has received approval from the USFDA to market its generic Atenolol tablets.<cite>Agencies</cite></figcaption>
      </figure>
      <p>Unichem Laboratories shares on Monday surged over 7 per cent after the company got approval from the US health regulator for Atenolol tablets.</p>
      <p>Shares of the drug firm gained 7.04 per cent to trade at Rs 164 on the BSE.</p>
      <p>On the NSE, the stock was up 7.22 per cent at Rs 164.</p>
      <p>Unichem Laboratories on Friday said it has received approval from the <a href="https://economictimes.indiatimes.com/topic/USFDA">USFDA</a> to market its generic Atenolol tablets used for the treatment of hypertension.</p>
      <p>"Unichem Laboratories Ltd has received ANDA approval for its Atenolol tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENORMIN (Atenolol) Tablets, 25 mg, 50 mg, and 100 mg, of Alvogen Malta Operations Ltd," the company said in a BSE filing.</p>
      <p>The filing came in the late evening on Friday.</p>
      <p>The product will be commercialised from the company's Ghaziabad plant, it added.</p>
    </article>
  </body>
</html>